Bayer to invest over €400m to boost modern contraception in LMICs
The investment will enhance production capabilities in Alajuela, Costa Rica and Turku, Finland, to meet global demand for…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
06 Oct 21
The investment will enhance production capabilities in Alajuela, Costa Rica and Turku, Finland, to meet global demand for…
09 Sep 21
The acquisition will add Rezurock, an FDA-approved treatment for chronic graft-versus-host disease (cGVHD), to Sanofi’s transplant portfolio
23 Aug 21
The antibody cocktail comprises casirivimab and imdevimab and leverages Regeneron's VelocImmune and VelociSuite technologies
21 Jul 21
The MHLW approval is based on a global Phase 3 trial which found Ronapreve reduced 70% hospitalisation or…
13 Jul 21
Novo Nordisk intends to initially develop the Phase 2 ready antibody PRX004 for the rare heart disease ATTR…
07 Jul 21
With the divestiture of Generic Rx Pharmaceutical business, Perrigo will become a pure-play global consumer self-care company
02 Jul 21
The acquisition of Fertin Pharma would support PMI’s goal of generating more than 50% revenues from smoke-free products…
02 Jul 21
ZyCoV-D is a plasmid DNA intradermal vaccine that can be stored at 2-8ºC, with stability at 25ºC for…
28 Jun 21
With a ready-to-dilute format and 1,000mg strength option, the drug helps in reducing contamination risks
25 Mar 21
Viraleze contains astodrimer sodium (SPL7013), a virucidal that irreversibly inactivates more than 99.9% of SARS-CoV-2, within one minute